Serina Therapeutics, Inc. (SER) Financials

SER Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 27.3 million 9.7 million
Dec. 31, 2025 7.0 million 7.0 million
Sept. 30, 2025 12.4 million 10.8 million
June 30, 2025 8.9 million 7.3 million

SER Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.6 million 1.1 million
Dec. 31, 2025 -6.0 million 948000
Sept. 30, 2025 -3.9 million 999000
June 30, 2025 -3.8 million 890000

SER Net Income

No data available :(

SER Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 24.5 million 3.0 million 159000
Dec. 31, 2025 4.8 million 2.9 million 196000
Sept. 30, 2025 8.6 million - 148000
June 30, 2025 6.0 million - 185000

SER Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 12.0 million
Dec. 31, 2025 10.2 million
Sept. 30, 2025 10.3 million
June 30, 2025 10.0 million

SER Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 25000 3.2 million 3.1 million -
Dec. 31, 2025 59000 3.4 million 2.8 million -
Sept. 30, 2025 13000 3.7 million 2.7 million -
June 30, 2025 46000 3.2 million 2.5 million -

SER Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 18000
Dec. 31, 2025 - 23000
Sept. 30, 2025 - 17000
June 30, 2025 130000 16000

SER Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SER

Price: $1.86

52 week price:
1.22
7.92

Earnings Per Share: -2.00 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 29.7 million

Links: